Alzheimer’s is associated with all 7 of the genes which restrict vitamin D from getting to tissues
Serum Parathyroid Hormone, 25-Hydroxyvitamin D, and Risk of Alzheimer’s Disease: A Mendelian Randomization Study
Nutrients 2018, 10(9), 1243; https://doi.org/10.3390/nu10091243
Susanna C. Larsson 1,,Matthew Traylor 2, Hugh S. Markus 2 and Karl Michaëlsson 3

Lower vitamin D in blood causes Alzheimer's Disease (Mendelian gene analysis) – Dec 2019
Vitamin D influences inflammation and Alzheimer’s genes (in mice) – March 2021
Information on Genes in Vitamin D Life
| Gene | 1. of pages | |
| Oct 2017 | Location | |
| CYP27A1 | 223 | Liver |
| CYP2R1 | 626 | Tissue |
| [Vitamin D Binding Protein | ||
| GC](/tags/vitamin-d-binding-protein-gc/) | 3,450 | Blood |
| CYP27B1 | 803 | Kidney & Tissue |
| Vitamin D Receptor | 6,030 | Cell Tissue |
| CYP24A1 | 745 | excrete excess |
📄 Download the PDF from Vitamin D Life
We conducted Mendelian randomization analyses to investigate the associations of serum parathyroid hormone (S-PTH) and serum 25-hydroxyvitamin D (S-25OHD) concentrations with Alzheimer’s disease (AD). Five and seven single nucleotide polymorphisms associated with S-PTH and S-25OHD concentrations, respectively, were used as instrumental variables.
Data for AD were acquired from the International Genomics of Alzheimer’s Project (17,008 AD cases and 37,154 controls). Genetically higher S-PTH concentrations were not associated with AD (odds ratio per standard deviation increase in S-PTH = 1.11; 95% CI 0.97–1.26; p = 0.12). In contrast, all seven 25OHD-increasing alleles were inversely associated with AD and two of the associations were statistically significant (p < 0.05). The odds ratio of AD per genetically-predicted one standard deviation increase in S-25OHD was 0.86 (95% CI 0.78–0.94; p = 0.002).
This study provides evidence that vitamin D may play a role in AD but
found no significant association between S-PTH and AD.